444 related articles for article (PubMed ID: 16754629)
1. Impact of pain in health related quality of life of patients with systemic sclerosis.
Georges C; Chassany O; Toledano C; Mouthon L; Tiev K; Meyer O; Ilie D; Rambeloarisoa J; Marjanovic Z; Cabane J; Sereni D; Pouchot J; Farge D
Rheumatology (Oxford); 2006 Oct; 45(10):1298-302. PubMed ID: 16754629
[TBL] [Abstract][Full Text] [Related]
2. Assessing disability and quality of life in systemic sclerosis: construct validities of the Cochin Hand Function Scale, Health Assessment Questionnaire (HAQ), Systemic Sclerosis HAQ, and Medical Outcomes Study 36-Item Short Form Health Survey.
Rannou F; Poiraudeau S; Berezné A; Baubet T; Le-Guern V; Cabane J; Guillevin L; Revel M; Fermanian J; Mouthon L
Arthritis Rheum; 2007 Feb; 57(1):94-102. PubMed ID: 17266096
[TBL] [Abstract][Full Text] [Related]
3. Quality of life and functional status in systemic sclerosis compared to other rheumatic diseases.
Johnson SR; Glaman DD; Schentag CT; Lee P
J Rheumatol; 2006 Jun; 33(6):1117-22. PubMed ID: 16622903
[TBL] [Abstract][Full Text] [Related]
4. Correlation of the degree of dyspnea with health-related quality of life, functional abilities, and diffusing capacity for carbon monoxide in patients with systemic sclerosis and active alveolitis: results from the Scleroderma Lung Study.
Khanna D; Clements PJ; Furst DE; Chon Y; Elashoff R; Roth MD; Sterz MG; Chung J; FitzGerald JD; Seibold JR; Varga J; Theodore A; Wigley FM; Silver RM; Steen VD; Mayes MD; Connolly MK; Fessler BJ; Rothfield NF; Mubarak K; Molitor J; Tashkin DP;
Arthritis Rheum; 2005 Feb; 52(2):592-600. PubMed ID: 15692967
[TBL] [Abstract][Full Text] [Related]
5. Dermatology life quality index in Thai patients with systemic sclerosis: a cross-sectional study.
Chularojanamontri L; Sethabutra P; Kulthanan K; Manapajon A
Indian J Dermatol Venereol Leprol; 2011; 77(6):683-7. PubMed ID: 22016275
[TBL] [Abstract][Full Text] [Related]
6. Health-related quality of life in systemic sclerosis as measured by the Short Form 36: relationship with clinical and biologic markers.
Del Rosso A; Boldrini M; D'Agostino D; Placidi GP; Scarpato A; Pignone A; Generini S; Konttinen Y; Zoppi M; Vlak T; Placidi G; Matucci-Cerinic M
Arthritis Rheum; 2004 Jun; 51(3):475-81. PubMed ID: 15188336
[TBL] [Abstract][Full Text] [Related]
7. Responsiveness of the SF-36 and the Health Assessment Questionnaire Disability Index in a systemic sclerosis clinical trial.
Khanna D; Furst DE; Clements PJ; Park GS; Hays RD; Yoon J; Korn JH; Merkel PA; Rothfield N; Wigley FM; Moreland LW; Silver R; Steen VD; Weisman M; Mayes MD; Collier DH; Medsger TA; Seibold JR; ;
J Rheumatol; 2005 May; 32(5):832-40. PubMed ID: 15868618
[TBL] [Abstract][Full Text] [Related]
8. Validity of the Saint George's Respiratory Questionnaire in the evaluation of the health-related quality of life in patients with interstitial lung disease secondary to systemic sclerosis.
Beretta L; Santaniello A; Lemos A; Masciocchi M; Scorza R
Rheumatology (Oxford); 2007 Feb; 46(2):296-301. PubMed ID: 16877463
[TBL] [Abstract][Full Text] [Related]
9. Correlates of the disability index of the health assessment questionnaire: a measure of functional impairment in systemic sclerosis.
Clements PJ; Wong WK; Hurwitz EL; Furst DE; Mayes M; White B; Wigley F; Weisman M; Barr W; Moreland L; Medsger TA; Steen V; Martin R; Collier D; Weinstein A; Lally E; Varga J; Weiner S; Andrews B; Abeles M; Seibold J
Arthritis Rheum; 1999 Nov; 42(11):2372-80. PubMed ID: 10555033
[TBL] [Abstract][Full Text] [Related]
10. Medical signs and symptoms associated with disability, pain, and psychosocial adjustment in systemic sclerosis.
Malcarne VL; Hansdottir I; McKinney A; Upchurch R; Greenbergs HL; Henstorf GH; Furst DE; Clements PJ; Weisman MH
J Rheumatol; 2007 Feb; 34(2):359-67. PubMed ID: 17304659
[TBL] [Abstract][Full Text] [Related]
11. Lower gastrointestinal symptoms and quality of life in patients with systemic sclerosis: a population-based study.
Franck-Larsson K; Graf W; Rönnblom A
Eur J Gastroenterol Hepatol; 2009 Feb; 21(2):176-82. PubMed ID: 19212206
[TBL] [Abstract][Full Text] [Related]
12. Impact of oral cyclophosphamide on health-related quality of life in patients with active scleroderma lung disease: results from the scleroderma lung study.
Khanna D; Yan X; Tashkin DP; Furst DE; Elashoff R; Roth MD; Silver R; Strange C; Bolster M; Seibold JR; Riley DJ; Hsu VM; Varga J; Schraufnagel DE; Theodore A; Simms R; Wise R; Wigley F; White B; Steen V; Read C; Mayes M; Parsley E; Mubarak K; Connolly MK; Golden J; Olman M; Fessler B; Rothfield N; Metersky M; Clements PJ;
Arthritis Rheum; 2007 May; 56(5):1676-84. PubMed ID: 17469162
[TBL] [Abstract][Full Text] [Related]
13. Patient preference disability questionnaire in systemic sclerosis: a cross-sectional survey.
Mouthon L; Rannou F; Bérezné A; Pagnoux C; Guilpain P; Goldwasser F; Revel M; Guillevin L; Fermanian J; Poiraudeau S
Arthritis Rheum; 2008 Jul; 59(7):968-73. PubMed ID: 18576298
[TBL] [Abstract][Full Text] [Related]
14. Measuring disease activity and functional status in patients with scleroderma and Raynaud's phenomenon.
Merkel PA; Herlyn K; Martin RW; Anderson JJ; Mayes MD; Bell P; Korn JH; Simms RW; Csuka ME; Medsger TA; Rothfield NF; Ellman MH; Collier DH; Weinstein A; Furst DE; Jiménez SA; White B; Seibold JR; Wigley FM;
Arthritis Rheum; 2002 Sep; 46(9):2410-20. PubMed ID: 12355489
[TBL] [Abstract][Full Text] [Related]
15. Clinical correlates of self-reported physical health status in systemic sclerosis.
Hudson M; Steele R; Lu Y; Thombs BD; Panopalis P; Baron M;
J Rheumatol; 2009 Jun; 36(6):1226-9. PubMed ID: 19447939
[TBL] [Abstract][Full Text] [Related]
16. Association of pruritus with quality of life and disability in systemic sclerosis.
El-Baalbaki G; Razykov I; Hudson M; Bassel M; Baron M; Thombs BD;
Arthritis Care Res (Hoboken); 2010 Oct; 62(10):1489-95. PubMed ID: 20506531
[TBL] [Abstract][Full Text] [Related]
17. Quality of life in patients with systemic sclerosis compared to the general population and patients with other chronic conditions.
Hudson M; Thombs BD; Steele R; Panopalis P; Newton E; Baron M;
J Rheumatol; 2009 Apr; 36(4):768-72. PubMed ID: 19228662
[TBL] [Abstract][Full Text] [Related]
18. The relationship of dyspnoea to function and quality of life in systemic sclerosis.
Baron M; Sutton E; Hudson M; Thombs B; Markland J; Pope J; Robinson D; Jones N; Docherty P; Abu-Hakima M; LeClercq S; Smith D; Mathieu JP
Ann Rheum Dis; 2008 May; 67(5):644-50. PubMed ID: 17728334
[TBL] [Abstract][Full Text] [Related]
19. The impact of psychological functioning upon systemic sclerosis patients' quality of life.
Hyphantis TN; Tsifetaki N; Siafaka V; Voulgari PV; Pappa C; Bai M; Palieraki K; Venetsanopoulou A; Mavreas V; Drosos AA
Semin Arthritis Rheum; 2007 Oct; 37(2):81-92. PubMed ID: 17512572
[TBL] [Abstract][Full Text] [Related]
20. The Disability Index of the Health Assessment Questionnaire is a predictor and correlate of outcome in the high-dose versus low-dose penicillamine in systemic sclerosis trial.
Clements PJ; Wong WK; Hurwitz EL; Furst DE; Mayes M; White B; Wigley F; Weisman M; Barr W; Moreland L; Medsger TA; Steen V; Martin RW; Collier D; Weinstein A; Lally E; Varga J; Weiner SR; Andrews B; Abeles M; Seibold JR
Arthritis Rheum; 2001 Mar; 44(3):653-61. PubMed ID: 11263780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
